Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS) "DEDAS"


Phase 1/2 Results N/A

Summary of Purpose

The purpose of this study was to explore trends in safety and efficacy, and to find the optimal dose for the subsequent phase III trial. The decision to initiate the phase III trial will depend on both safety (incidence of symptomatic intracranial hemorrhage) and efficacy (reperfusion measured by MRI and correlating with clinical outcome) profiles. The safety (incidence of symptomatic intracranial haemorrhage)...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 March 2008.

1 Mar 2003 12 Mar 2008 1 Oct 2004 1 Oct 2004 1 Mar 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available